NovaBay Pharmaceuticals Inc (NYSE American:NBY)

Delayed Data
As of Feb 23
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for NovaBay Pharmaceuticals Inc have a median target of 6.13, with a high estimate of 8.00 and a low estimate of 5.00. The median estimate represents a +80.15% increase from the last price of 3.40.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in NovaBay Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 70.83%
Growthannually 59.05%


Growthquarterly 46.09%
Growthannually 50.32%
Key to the earnings and sales forecast charts.